long-acting insulin substitutes." Last November, Novo Nordisk announced it would stop selling the injectable FlexPen version of Levemir this month and halt sales of Levemir vials by December 2024.

can buy Novo Nordisk’s insulin products for $35 per month for the next five years. The settlement resolves the Attorney General’s 2018 lawsuit alleging that Novo Nordisk deceptively priced its ...

South Africa's competition watchdog is investigating drugmakers Novo Nordisk and Sanofi over possible anti-competitive ...

The new PenCycle programme covers Novo Nordisk's FlexPen and FlexTouch devices, which are used to dispense insulin and other medications. Users of the devices in the UK will shortly be able to ...

Novo Nordisk has acquired UK start-up Ziylo in a deal worth up to $800m in a bid to develop the world’s first “smart” insulin, capable of modulating its effectiveness depending on how much ...

FlexPen ® is a pre-filled dial-a-dose insulin pen able to deliver from 1 to 60 units of Levemir ® in increments of 1 unit. This medicine is not addictive. Levemir ® FlexPen ® is available only ...

Two prefilled, disposable insulin pen devices were used: InnoLet and FlexPen (Novo Nordisk). Because the hospital has one preferred formulary manufacturer for insulin analogues, orders from ...

Novo Nordisk A/S and Sanofi are facing an investigation in South Africa over concerns about potential anti-competitive practices in the human insulin pen market.